Compare BWMN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMN | ETON |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 498.8M |
| IPO Year | 2021 | 2018 |
| Metric | BWMN | ETON |
|---|---|---|
| Price | $35.35 | $16.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $41.13 | $29.67 |
| AVG Volume (30 Days) | 142.3K | ★ 208.3K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $474,277,000.00 | $70,316,000.00 |
| Revenue This Year | $16.92 | $107.23 |
| Revenue Next Year | $9.41 | $29.72 |
| P/E Ratio | $37.13 | ★ N/A |
| Revenue Growth | 16.73 | ★ 102.77 |
| 52 Week Low | $17.90 | $11.09 |
| 52 Week High | $45.83 | $23.00 |
| Indicator | BWMN | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 48.77 |
| Support Level | $32.89 | $15.83 |
| Resistance Level | $34.99 | $17.17 |
| Average True Range (ATR) | 1.29 | 0.62 |
| MACD | 0.15 | 0.06 |
| Stochastic Oscillator | 67.02 | 50.63 |
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.